Frontlight ResearchEarly access
Trial site
Przychodnia Lekarska "KOMED"
- 9running trials
- 7closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Metastatic breast cancer3 trials
- Childhood cancers2 trials
- Colorectal cancer2 trials
- Head and neck cancer2 trials
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Prostate cancer1 trial
- Phase
- Phase 311 trials
- Phase 24 trials
- Phase 2/31 trial
- Status
- Active, not recruiting7 trials
- Completed7 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Merck Sharp & Dohme LLC4 trials
- Pfizer3 trials
- Incyte Corporation2 trials
- AstraZeneca1 trial
- Bristol-Myers Squibb1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Active, not recruiting
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer2 recruiting
Closed trials
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026